Skip To Main Content

Education Articles

Sort by

Filters

Resetten
  • Therapeutische gebieden
Personalized approach in T2D is key for success

Personalized approach in T2D is key for success

The Sanofi webinar ‘Act Now for Impact: Glycemic Control and Beyond’ focuses on recent advancements in treating type 2 diabetes (T2D), emphasizing a personalized approach for better outcomes. Prof. Frank Nobels (Belgium), prof. De Galan (the Netherlands) and Prof Björn Eliasson (Sweden) addressed various aspects of T2D treatment in the present era.

DERM 360° Roundtable: Patient Reported Outcome Measures (PROMs) in Clinical Practice

DERM 360° Roundtable: Patient Reported Outcome Measures (PROMs) in Clinical Practice

3rd of December 2024

A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I

A phase III randomized trial evaluating alirocumab 300 mg every 4 weeks as monotherapy or add-on to statin: ODYSSEY CHOICE I

Roth Eli M et al. Atherosclerosis vol. 254 (2016): 254-262

Introduction to hand and foot dermatitis

Introduction to hand and foot dermatitis

Hot topics in atopic dermatitis: Hear it from the experts

Hot topics in atopic dermatitis: Hear it from the experts

DERM 360° 6.11.24

DERM 360° 6.11.24

Clinical challenges to achieve long-term disease control within treatment of moderate to severe AD.

Why Don’t We Strike Early, Strike Strong?

Why Don’t We Strike Early, Strike Strong?

Prof. Dr. Halvorsen, Prof. Dr. Sinnaeve & Prof. Dr. Martens

COPD Research Forum

COPD Research Forum

Replay webinar 'Vaccinatie bij ouderen, met focus op grieppreventie' - Prof. dr. Van Bleyenbergh

Replay webinar 'Vaccinatie bij ouderen, met focus op grieppreventie' - Prof. dr. Van Bleyenbergh

A Quick Guide to Nirsevimab SmPC (2024)

A Quick Guide to Nirsevimab SmPC (2024)

Rhino Rounds International 2024 - Interview

Rhino Rounds International 2024 - Interview

Slowly Expanded Lesions

Slowly Expanded Lesions

A candidate biomarker for smoldering neuroinflammation in MS.